CNQ · BNXT.CN
BioNxt Solutions Inc.
CA$0.29CA$0.00 (0.0%)
BioNxt Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.86% below the high.
Loading market information…
CNQ · PREV.CN · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 05:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
PreveCeutical Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PreveCeutical Medical Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.29CA$0.00 (0.0%)
BioNxt Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.86% below the high.
CA$0.07CA$0.00 (0.0%)
MediPharm Labs Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CA$0.11+CA$0.01 (+10.0%)
Rapid Dose Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 42.11% below the high.
CA$0.10-CA$0.01 (-4.76%)
Avicanna Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.29% below the high.
CA$1.90CA$0.00 (0.0%)
InnoCan Pharma Corporation’s quoted price sits in the lower half of its reported 52-week range, 90.08% below the high.
CA$0.04CA$0.00 (0.0%)
Glow Lifetech Corp.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
CA$0.02+CA$0.01 (+50.0%)
Blueberries Medical Corp.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
